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updated the details of their dissection cohort published just
a few years ago. It now includes 50 patients treated for acute
type B aortic dissection using TEVAR. Their technical success in
treating these patients is reported as 98%. It should be stressed,
however, that the reintervention rate at a mean follow-up of 34
months was signiﬁcant, with 26% of the patients requiring
secondary procedures at a mean interval of 4.5 months. They
have demonstrated excellent outcomes in this difﬁcult group of
patients and have added to the growing literature of support in
favor of TEVAR for acute aortic syndromes.
I have three questions for the authors:
1. It has been our practice since 2008 to routinely extend the
endograft treatment to within 5-8 cm of the celiac artery to
minimize the incidence of reintervention rates. In light to
your previous report, did you compare this new cohort of
patients to determine if there were differences in outcomes
or practice patterns over time that altered your results?
2. You have detailed the use of IVUS and its utility in performing
these procedures. It appears from the manuscript, however,
that you rely on angiography and TEE to determinecompleteness of the repair. Can you explain the role of
IVUS in determining unresolved dynamic malperfusion
compared to TEE and angiography?
3. Lastly, it has been our experience, as well as others, that
patients with DeBakey type IIIA dissections have better results
with less reinterventions than those with type IIIB dissections.
Did you speciﬁcally look at this subgroup in you analysis?
Dr Jennifer M. Hanna. So, to the ﬁrst question, our practice
has evolved in that we now have a much lower threshold to pave
the aorta down to the celiac axis in order to cover any and all
thoracic fenestrations that are either seen on angiography or
TEE in the OR. Ultimately, if we saw persistent ﬂow in the false
lumen, then we would not hesitate to cover that area.
As to the second question, this brings up a good point.
Although not mentioned in the talk, IVUS is actually used to
conﬁrm true lumen re-expansion and resolution of dynamic mal-
perfusion after thoracic endografting with or without distal stent
graft placement. It, therefore, plays a complimentary role to
angiography.
As to the last question, there were no type IIIA endoleaks in
our patient cohort.
